|
Newsletter
OTC Journal Newsletter
Email : info@otcjournal.com To OTC Journal Members:
For those subscribers that did not notice the action on Tuesday of this past week, Mirage Holdings (OTC BB: MGHI), our current profile, traded 216,800 shares, and hit a high of $4.375. Not only is this the highest volume in the stock's history, but it is also the highest level the stock has achieved since we released our profile in January. Since Tuesday, the volume quieted down, and the stock retrenched to where it closed today at $3.31. Tuesday was important for several reasons. First, the volume had nothing to do with any information we released to our members, and there was no press release associated with this surge. This is a clear indication that there are other investors beginning to recognize this Company. Second, an observation for our members that are technicians: You should have noticed that the highs are now getting higher, and the lows are getting higher. This is an excellent technical sign which suggest higher levels in the future. Third: We are always the first to present these undiscovered companies, and it is always interesting to see how a stock behaves that has no following prior to our profile. In the case of Mirage Holdings (OTC BB: MGHI), it is clear that there was stock for sale when we first covered the company. Each day as more shares become accumulated by new shareholders, we get closer to a day when the supply will completely dry up. We don't know when that will happen, but we know that if this Company continues to announce contract signings, a pay day for investors is inevitable.
DISCLAIMER The OTC Journal.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. All statements and expressions are the sole opinions of the editors and are subject to change without notice. This profile is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. The editor, members of the editor's family, and/or entities with which they are affiliated, may own stock in and have other financial dealings with the companies who appear in the publication. OTC Journal Management, the parent company of the OTC Journal Newsletter, has been paid a fee of $50,000 in cash, and 50,000 shares of restricted stock as compensation for representing Mirage Holdings for a period of one year. The OTC Journal.com critiques may contain forward looking statements relating to the expected capabilities of the companies mentioned herein. THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCJOURNAL.com. We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. |
To subscribe to our newsletter, please enter your email address below. Market Summary
|


